.
Welcome to the OracleBio Q1 2022 Wrap Up! In this edition, we wrap up all of our latest news and insights from Jan-March. There's a lot to cover, so grab a tea or coffee ☕TRENDING BLOG Using Deep Learning to address Staining Variance across Multiplex IF images...
OracleBio Chief Scientific Officer, Lorcan Sherry, was invited to be part of Ultivue's interactive panel for their virtual event, 'Digital Insights to Tumor Biology: Uncovering the Complexities of the Tumor Immune Microenvironment with Digital Pathology'. Lorcan...
We are proud to announce the launch of OracleBio's GCP Image Analysis Services. This latest service offering strengthens the company’s position as a global leader in quantitative digital pathology, expanding the company’s foothold in the clinical market. Our new...
We are always on the lookout for ambitious, hard working individuals to join us. As OracleBio continues to grow, we are looking to expand and strengthen our operations by employing a number of Histopathology Image Analysis Scientists to join the team at an exciting...
OracleBio is pleased to welcome Dr Gabriele Kohnen to the team as Senior Clinical Pathologist. Gabriele is a Consultant Clinical Pathologist with 25 years experience in Diagnostic Healthcare. She has specialist expertise in liver, gastrointestinal tract, placenta and...
OracleBio and Ultivue have announced a collaborative partnership to help further insights and advance personalized tumor characterization in translational and clinical oncology research and drug development using multiplex immunofluorescence staining and imaging. The...
OracleBio continues to enhance its digital pathology software capabilities by integrating Indica Labs HALO AI™ into its image analysis workflow. This latest step in OracleBio’s development will enable the quantitative digital pathology services provider to meet...
GLASGOW, UK – OracleBio, a leading provider of digital pathology services, will collaborate with the University of Glasgow, NHS, BioClavis and Canon Medical on a project to develop a precision diagnostic tool to transform bowel cancer screening in the UK. The INCISE...
OracleBio is pleased to announce an expansion of its digital pathology software capabilities to include unlimited Visiopharm software licenses for high throughput image analysis processing in the cloud. The move to an infinitely scalable solution will enable the...
We would like to assure all our clients that OracleBio are fully set up to deal with any disruptions that may be enforced upon us due to the COVID-19 outbreak. Remote working has been fully established at OracleBio for a number of years and is part of our standard...
OracleBio is pleased to welcome Dr James Going, who has recently joined the team as Senior Pathologist. James brings a huge amount of expertise to the role with over 39 years of pathology experience. Currently working as a Consultant Clinical Pathologist in the NHS,...
Dr Lorcan Sherry, OracleBio’s Chief Scientific Officer, was recently interviewed by Labs Explorer, an online R&D marketplace that offers a platform for researchers to search for R&D partners, increase visibility and gain financing. In the interview,...